# Orange County Bancorp, Inc.: financial statements, quarterly

OBT · Nasdaq · CIK 1754226 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/obt.md) · [Financials](/companies/obt/financials.md) · [Filings](/companies/obt/filings.md) · [Insiders](/companies/obt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/obt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [7.6](/filings/0001558370-23-018985.md) | [9.4 d](/filings/0001558370-24-004354.md) | [9.5](/filings/0001558370-24-008264.md) | [8.4](/filings/0001558370-24-011803.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.3](/filings/0001558370-24-015500.md) | [2.6 d](/filings/0001558370-25-003120.md) | [2.3](/filings/0001558370-25-007391.md) | [2.0](/filings/0001558370-25-011005.md) | [0.8](/filings/0001104659-25-108979.md) | [1.8 d](/filings/0001104659-26-028308.md) | [2.6](/filings/0001104659-26-058511.md) | [3.1](/filings/0001104659-26-093345.md) | [3.0](/filings/0001104659-25-108979.md) | [1.2 d](/filings/0001104659-26-028308.md) | [3.3](/filings/0001104659-26-058511.md) | [(2.1)](/filings/0001104659-26-093345.md) |
| Net income | $m | [9.0](/filings/0001558370-24-015500.md) | [8.1 d](/filings/0001558370-25-003120.md) | [9.3](/filings/0001558370-25-007391.md) | [8.2](/filings/0001558370-25-011005.md) | [3.2](/filings/0001104659-25-108979.md) | [7.2 d](/filings/0001104659-26-028308.md) | [8.7](/filings/0001104659-26-058511.md) | [10.5](/filings/0001104659-26-093345.md) | [10.0](/filings/0001104659-25-108979.md) | [12.4 d](/filings/0001104659-26-028308.md) | [11.3](/filings/0001104659-26-058511.md) | [13.7](/filings/0001104659-26-093345.md) |
| Diluted EPS | $ per share | [1.61](/filings/0001558370-24-015500.md) | not reported | [0.82](/filings/0001558370-25-007391.md) | [0.73](/filings/0001558370-25-011005.md) | [0.28](/filings/0001104659-25-108979.md) | not reported | [0.77](/filings/0001104659-26-058511.md) | [0.87](/filings/0001104659-26-093345.md) | [0.75](/filings/0001104659-25-108979.md) | not reported | [0.85](/filings/0001104659-26-058511.md) | [1.02](/filings/0001104659-26-093345.md) |
| Basic EPS | $ per share | [1.61](/filings/0001558370-24-015500.md) | not reported | [0.82](/filings/0001558370-25-007391.md) | [0.73](/filings/0001558370-25-011005.md) | [0.28](/filings/0001104659-25-108979.md) | not reported | [0.77](/filings/0001104659-26-058511.md) | [0.87](/filings/0001104659-26-093345.md) | [0.75](/filings/0001104659-25-108979.md) | not reported | [0.85](/filings/0001104659-26-058511.md) | [1.02](/filings/0001104659-26-093345.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [2,447](/filings/0001558370-24-015500.md) | [2,485](/filings/0001558370-25-003120.md) | [2,453](/filings/0001558370-25-007391.md) | [2,481](/filings/0001558370-25-011005.md) | [2,519](/filings/0001104659-25-108979.md) | [2,510](/filings/0001104659-26-028308.md) | [2,560](/filings/0001104659-26-058511.md) | [2,606](/filings/0001104659-26-093345.md) | [2,636](/filings/0001104659-25-108979.md) | [2,659](/filings/0001104659-26-093345.md) | [2,706](/filings/0001104659-26-058511.md) | [2,800](/filings/0001104659-26-093345.md) |
| Total liabilities | $m | [2,303](/filings/0001558370-23-018985.md) | [2,320](/filings/0001558370-25-003120.md) | [2,284](/filings/0001558370-24-008264.md) | [2,304](/filings/0001558370-24-011803.md) | [2,326](/filings/0001558370-24-015500.md) | [2,324](/filings/0001104659-26-028308.md) | [2,359](/filings/0001558370-25-007391.md) | [2,354](/filings/0001558370-25-011005.md) | [2,366](/filings/0001104659-25-108979.md) | [2,375](/filings/0001104659-26-093345.md) | [2,414](/filings/0001104659-26-058511.md) | [2,494](/filings/0001104659-26-093345.md) |
| Shareholders' equity | $m | [144](/filings/0001558370-24-015500.md) | [165](/filings/0001104659-26-028308.md) | [169](/filings/0001558370-25-011005.md) | [178](/filings/0001104659-25-108979.md) | [193](/filings/0001104659-25-108979.md) | [186](/filings/0001104659-26-093345.md) | [201](/filings/0001104659-26-093345.md) | [253](/filings/0001104659-26-093345.md) | [270](/filings/0001104659-25-108979.md) | [284](/filings/0001104659-26-093345.md) | [292](/filings/0001104659-26-093345.md) | [307](/filings/0001104659-26-093345.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.9 d](/filings/0001558370-24-015500.md) | [16.0 d](/filings/0001558370-25-003120.md) | [2.3](/filings/0001558370-25-007391.md) | [9.3 d](/filings/0001558370-25-011005.md) | [10.2 d](/filings/0001104659-25-108979.md) | [12.8 d](/filings/0001104659-26-028308.md) | [4.8](/filings/0001104659-26-058511.md) | [(5.0) d](/filings/0001104659-26-093345.md) | [30.2 d](/filings/0001104659-25-108979.md) | [13.8 d](/filings/0001104659-26-028308.md) | [10.2](/filings/0001104659-26-058511.md) | [12.6 d](/filings/0001104659-26-093345.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001558370-24-015500.md) | [0.5 d](/filings/0001558370-25-003120.md) | [0.3](/filings/0001558370-25-007391.md) | [0.1 d](/filings/0001558370-25-011005.md) | [0.3 d](/filings/0001104659-25-108979.md) | [1.1 d](/filings/0001104659-26-028308.md) | [0.5](/filings/0001104659-26-058511.md) | [0.7 d](/filings/0001104659-26-093345.md) | [0.6 d](/filings/0001104659-25-108979.md) | [0.7 d](/filings/0001104659-26-028308.md) | [0.6](/filings/0001104659-26-058511.md) | [0.3 d](/filings/0001104659-26-093345.md) |
| Dividends paid | $m | [1.3 d](/filings/0001558370-24-015500.md) | [1.3 d](/filings/0001558370-25-003120.md) | [1.3](/filings/0001558370-25-007391.md) | [1.3 d](/filings/0001558370-25-011005.md) | [1.3 d](/filings/0001104659-25-108979.md) | [1.4 d](/filings/0001104659-26-028308.md) | [1.5](/filings/0001104659-26-058511.md) | [1.5 d](/filings/0001104659-26-093345.md) | [1.7 d](/filings/0001104659-25-108979.md) | [2.4 d](/filings/0001104659-26-028308.md) | [2.4](/filings/0001104659-26-058511.md) | [2.4 d](/filings/0001104659-26-093345.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.6](/filings/0001558370-23-018985.md) | [5.6](/filings/0001558370-24-008264.md) | [5.6](/filings/0001558370-24-011803.md) | [5.6](/filings/0001558370-24-015500.md) | [11.3](/filings/0001558370-25-007391.md) | [11.3](/filings/0001558370-25-011005.md) | [11.3](/filings/0001104659-25-108979.md) | [11.3](/filings/0001104659-26-058511.md) | [12.0](/filings/0001104659-26-093345.md) | [13.3](/filings/0001104659-25-108979.md) | [13.4](/filings/0001104659-26-058511.md) | [13.4](/filings/0001104659-26-093345.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,407,963 at 2026-08-05, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093345.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.